Does Grifols (BME:GRF) Offer Opportunity After Sharp Share Price Declines And Debt Concerns [Yahoo! Finance]
GRIFOLS SA S/ADR (GIKLY)
NASDAQ:AMEX Investor Relations:
grifols.com/en/web/international/investor-relations/home-page
Company Research
Source: Yahoo! Finance
If you are wondering whether Grifols at €9.22 is a bargain or a value trap, you are in the right place to size up what the current share price might actually represent. The stock has recently been weak, with a 7 day return of an 8.4% decline, a 30 day return of a 15.6% decline, a year to date return of a 17.7% decline, and a 5 year return of a 57.0% decline, which may have changed how investors see both its potential and its risks. Recent headlines around Grifols have mainly focused on its debt load, governance questions, and the strength of its plasma based medicines business. Together, these shape how comfortable investors feel with the balance sheet and future funding needs. These stories help explain why the share price has been under pressure and why opinions on the stock are currently quite divided. On our checks, Grifols scores 5 out of 6 on valuation, and you can see the full breakdown in its valuation score. Next, we will look at what traditional methods like P/E, P/S
Show less
Read more
Impact Snapshot
Event Time:
GIKLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GIKLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GIKLY alerts
High impacting GRIFOLS SA S/ADR news events
Weekly update
A roundup of the hottest topics
GIKLY
News
- Hyprho-D (Grifols, Kamada) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Plasbumin-5 (Grifols Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Albuked (Kedrion Biopharma, Grifols) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance